Prospective Study of Empiric Monotherapy with Ceftazidime for Low-Risk Grade IV Febrile Neutropenia after Cytotoxic Chemotherapy in Cancer Patients

Publisher： Karger

E-ISSN： 1421-9794|52|4|185-189

ISSN： 0009-3157

Source： Chemotherapy, Vol.52, Iss.4, 2006-06, pp. : 185-189

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Ceftriaxone Monotherapy in the Treatment of Low-Risk Febrile Neutropenia

By  

Chemotherapy, Vol. 44, Iss. 5, 1998-08 ,pp. : 343-354

Karger

Access to resources Recommend Favorite

A Comparative Study of Cefepime versus Ceftazidime as Empiric Therapy of Febrile Episodes in Neutropenic Patients

By  

Chemotherapy, Vol. 45, Iss. 5, 1999-08 ,pp. : 370-379

Karger

Access to resources Recommend Favorite

Retrospective Analysis of the Risk Factors for Grade IV Neutropenia in Oesophageal Cancer Patients Treated with a Docetaxel, Cisplatin, and 5-Fluorouracil Regimen

By  

Chemotherapy, Vol. 62, Iss. 4, 2017-04 ,pp. : 215-224

Karger

Access to resources Recommend Favorite

Treatment of Febrile Neutropenia with Cefepime Monotherapy

By  

Chemotherapy, Vol. 47, Iss. 3, 2001-04 ,pp. : 226-231

Karger

Access to resources Recommend Favorite

Malaria Parasitemia Associated with Febrile Neutropenia in African Patients Undergoing Chemotherapy for Haematological Malignancies

By  

Chemotherapy, Vol. 54, Iss. 2, 2008-02 ,pp. : 117-119

Karger

Access to resources Recommend Favorite